序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
34042-85-8 |
Sudoxicam |
≥98% |
50mg, 100mg, 250mg |
询价 |
2 |
1027102-49-3 |
UGM-IN-2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
3 |
1044503-04-9 |
Sudoterb HCl(LL3858) |
≥98% |
|
询价 |
4 |
80-33-1 |
Chlorfenson |
≥98% |
50mg, 100mg, 250mg |
询价 |
5 |
624-01-1 |
5-Oxodecanoic acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
6 |
1026295-98-6 |
HDAC-IN-6 |
≥98% |
|
询价 |
7 |
1238944-56-3 |
HDAC-IN-20 |
≥98% |
50mg, 100mg, 250mg |
询价 |
8 |
2316-26-9 |
3,4-Dimethoxycinnamic acid |
|
100mg |
询价 |
9 |
1884231-52-0 |
HDAC8-IN-20a |
≥98% |
50mg, 100mg, 250mg |
询价 |
10 |
6953-61-3 |
HDAC8-IN-2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
11 |
960374-59-8 |
ONX-0914(PR-957) |
|
|
询价 |
12 |
1239908-20-3 |
MLN9708(Ixazomib citrate) |
|
|
询价 |
13 |
2235382-05-3 |
HDAC6 degrader 9c |
≥98% |
50mg, 100mg, 250mg |
询价 |
14 |
1451042-19-5 |
HDAC3-IN-T326 |
≥98% |
50mg, 100mg, 250mg |
询价 |
15 |
1451042-18-4 |
HDAC3-IN-T247 |
≥98% |
50mg, 100mg, 250mg |
询价 |
16 |
675184-27-7 |
HCV-371 |
≥98% |
50mg, 100mg, 250mg |
询价 |
17 |
691852-36-5 |
HCV-086 |
≥98% |
50mg, 100mg, 250mg |
询价 |
18 |
18997-39-2 |
HC-3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
19 |
312595-37-2 |
HC103A |
≥98% |
50mg, 100mg, 250mg |
询价 |
20 |
91216-38-5 |
HC102A |
≥98% |
50mg, 100mg, 250mg |
询价 |
21 |
1628291-95-1 |
HC-070 |
≥98% |
|
询价 |
22 |
883031-03-6 |
HC-067047 |
≥98% |
50mg, 100mg, 250mg |
询价 |
23 |
7733-96-2 |
HC-056456 |
≥98% |
50mg, 100mg, 250mg |
询价 |
24 |
18671-82-4 |
HC 9016 |
≥98% |
50mg, 100mg, 250mg |
询价 |
25 |
1426544-54-8 |
HBX28258 |
≥98% |
50mg, 100mg, 250mg |
询价 |
26 |
1426944-49-1 |
HBX19818 |
≥98% |
50mg, 100mg, 250mg |
询价 |
27 |
865773-15-5 |
PF-03084014 |
≥98% |
50mg, 100mg, 250mg |
询价 |
28 |
40114-84-9 |
HBX |
≥98% |
50mg, 100mg, 250mg |
询价 |
29 |
2056899-56-8 |
HBT-O |
≥98% |
50mg, 100mg, 250mg |
询价 |
30 |
489408-02-8 |
HBT1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
31 |
944547-46-0 |
Mycro3 |
≥98% |
|
询价 |
32 |
957011-15-3 |
HBF-0259 |
≥98% |
|
询价 |
33 |
890605-54-6 |
Heclin |
≥98% |
50mg, 100mg, 250mg |
询价 |
34 |
1793063-59-8 |
HEC72702 |
≥98% |
|
询价 |
35 |
2697-85-0 |
HE-2200 |
≥98% |
50mg, 100mg, 250mg |
询价 |
36 |
28507-02-0 |
HE-2000 |
≥98% |
50mg, 100mg, 250mg |
询价 |
37 |
1382469-16-0 |
HDP-Mimic C4 |
≥98% |
50mg, 100mg, 250mg |
询价 |
38 |
147751-31-3 |
HDL376 |
≥98% |
50mg, 100mg, 250mg |
询价 |
39 |
85-86-9 |
Sudan III |
≥98% |
50mg, 100mg, 250mg |
询价 |
40 |
80037-86-1 |
Succinylacetone pyrrole |
≥98% |
50mg, 100mg, 250mg |
询价 |
41 |
51568-18-4 |
Succinylacetone |
≥98% |
|
询价 |
42 |
101496-69-9 |
Succinimide,N-(5-(p-aminophenoxy)pentyl)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
43 |
304-55-2 |
Succimer |
≥98% |
50mg, 100mg, 250mg |
询价 |
44 |
251356-32-8 |
SU9518 |
≥98% |
50mg, 100mg, 250mg |
询价 |
45 |
57-09-0 |
Cetrimonium bromide |
≥98% |
50mg, 100mg, 250mg |
询价 |
46 |
1055412-47-9 |
SU5614 |
≥98% |
|
询价 |
47 |
550999-74-1 |
Encenicline HCl salt(EVP6124 MT4666) |
≥98% |
|
询价 |
48 |
15966-93-5 |
SU-5408 |
≥98% |
|
询价 |
49 |
186610-89-9 |
SU4984 |
≥98% |
50mg, 100mg, 250mg |
询价 |
50 |
5812-07-7 |
SU-4312 |
≥98% |
|
询价 |
51 |
184003-14-3 |
SU-200 |
≥98% |
50mg, 100mg, 250mg |
询价 |
52 |
251356-45-3 |
SU16f |
≥98% |
50mg, 100mg, 250mg |
询价 |
53 |
155651-56-2 |
Fce 28260 |
≥98% |
|
询价 |
54 |
168835-82-3 |
SU-1498 |
≥98% |
|
询价 |
55 |
627908-92-3 |
SU14813 |
≥98% |
|
询价 |
56 |
12379-49-6 |
SU-13197 |
≥98% |
50mg, 100mg, 250mg |
询价 |
57 |
688036-19-3 |
SU-11752 |
≥98% |
50mg, 100mg, 250mg |
询价 |
58 |
326914-10-7 |
SU11652 |
≥98% |
50mg, 100mg, 250mg |
询价 |
59 |
1799711-21-9 |
dBET1 |
|
5mg, 10mg, 25mg |
询价 |
60 |
347396-82-1 |
Ranibizumab |
|
1mg |
询价 |